Onconetix, Inc. Stock Issued During Period, Shares, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Onconetix, Inc. stock issued during period, shares, conversion of units for the quarter ending 2023-09-30 was 0.00 shares.
- Onconetix, Inc. stock issued during period, shares, conversion of units for the quarter ending 2023-06-30 was 0.00 shares.
- Onconetix, Inc. stock issued during period, shares, conversion of units for the quarter ending 2023-03-31 was 221.00K shares.
- Onconetix, Inc. stock issued during period, shares, conversion of units for the quarter ending 2022-12-31 was 0.00 shares.
- Onconetix, Inc. stock issued during period, shares, conversion of units for fiscal 2022 was 221.00K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Units 3 month | Stock Issued During Period, Shares, Conversion of Units 12 month |
|---|---|---|
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | 221.00K shares derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | |
| 2023-03-31 | 221.00K shares 10-Q · filed 2023-05-12 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 221.00K shares 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |